课题基金 / 基金详情

Stability Change of Tetrameric Structure of Tumor Suppressor Protein p53 in Mutation and Evolution, and Threshold for Loss of Tumor Suppressor Activity in Terms of Disruption of the Tetrameric Structure.

Stability Change of Tetrameric Structure of Tumor Suppressor Protein p53 in Mutation and Evolution, and Threshold for Loss of Tumor Suppressor Activity in Terms of Disruption of the Tetrameric Structure.
肿瘤抑制蛋白p53四聚体结构在突变和进化中的稳定性变化,以及四聚体结构破坏导致肿瘤抑制活性丧失的阈值。
批准号:
21310133
负责人:
SAKAGUCHI Kazuyasu
金额:
$11.65万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

SAKAGUCHI Kazuyasu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The tumor suppressor p53 induces cell cycle arrest and apoptosis in response to genotoxic stress. About 50% of human tumors have TP53 gene mutations ; most are missense ones that presumably lower p53's tumor suppressor activity. In this study, we explored the effects of known tumor-derived missense mutations on the stability and oligomeric structure of p53. The results suggested that threshold for loss of tumor suppressor activity in terms of the disruption of p53's tetrameric structure could be extremely low. We developed a calixarene derivative that could increase the tetrameric stability of the mutant R337H, which is found in Li-Fraumeni syndrome, a hereditary disorder characterized by familial clusters of early-onset multiple tumors. We also showed that the tetramer stability increased through the evolution of vertebrates : fish-amphibian-bird and mammals. The results suggested that the folding of the tetramerization domain would tightly control its functional expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of Peptide Oligomerization Mediated by p53 Tetramerization Domain on Biomineralization Activity
p53 四聚化结构域介导的肽寡聚化对生物矿化活性的影响
DOI: --
发表时间: 2011
期刊: Peptide Sci.
影响因子: --
作者: [T. Sakaguchi, R. Kamada, and K. Sakaguchi]
通讯作者: and K. Sakaguchi
Probing Phenylalanine Environments in Oligomeric Structures Phenylalanine with Pentafluoronhenvlalanine and Cvclohexvlalanine.
用五氟代丙氨酸和环己基丙氨酸探测低聚结构中的苯丙氨酸环境。
DOI: --
发表时间: 2011
期刊: Biopolymers
影响因子: 2.9
作者: [M.Fernandez, S.Fujii, H.Kono, A.Sarai, T.Nomura]
通讯作者: T.Nomura
Low Threshold of Destabilization for Loss of Tumor Suppressor Activity of p53 : A Quantitative Analysis of p53 Tetramerization Domain Mutants.
p53 肿瘤抑制活性丧失的不稳定低阈值:p53 四聚化结构域突变体的定量分析。
DOI: --
发表时间: 2011
期刊: Peptide Science
影响因子: 2.4
作者: [Ono, E., Homma, Y., Horikawa, M., Kunikane-Doi, S., Imai, H., Takahashi, S., Kawai, Y., Ishiguro, M., Fukui, Y., Nakayama,T, R.Kamada]
通讯作者: R.Kamada
p53誘導性ボスファターゼPPM1D阻害剤における特定に配向する疎水性部位
p53 诱导的磷酸酶 PPM1D 抑制剂中特定定向的疏水位点
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Inokoshi J, Matsuhama M, Miyake M, Ikeda H, Tomoda H., H.Yagi]
通讯作者: H.Yagi
81
    Control of Bioreaction via Oligomerization and Orientation of Tumor Suppressor Protein p53 Tetramer
    • 批准号:
      24310152
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.56万
    • 财政年份:
      2012
    • 负责人:
      SAKAGUCHI Kazuyasu
    • 依托单位:
    Inhibition of tumor suppressor protein p53-dependent transcription by a tetramerization domain peptide via hetero-oligomerization
    • 批准号:
      23651210
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      SAKAGUCHI Kazuyasu
    • 依托单位:
    Inactivation of Tumor Suppressor Protein p53 by Mutations in the Tetramerization Domain and Stabilizing Methods for the Tetrameric Structure
    • 批准号:
      18310140
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.1万
    • 财政年份:
      2006
    • 负责人:
      SAKAGUCHI Kazuyasu
    • 依托单位:
    Design and development of tumor suppressor protein p53 variant that cannot form heterooligomers with the wild-type protein
    国内基金
    海外基金
    瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
    • 批准号:
      JCZRLH202600778
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    SDC1通过MMP11+CAF的细胞外基质重塑促进子宫颈癌化学免疫联合治疗耐药的机制研究
    • 批准号:
      JCZRQNB202600504
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    多模态精准导航引导肝内胆管癌淋巴结清扫的动态示踪与机制探索
    抗BNLF2b抗体联合circRNA构建鼻咽癌早期诊断模型及机制研究